Physician profile

Seema Rasheed

Physical Medicine & Rehabilitation · Pearland, TX

NPI 1801081039

$13,464.26

in general payments reported to CMS, 2019-2025

45 companies · $1,866 in 2025

The $1,866 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,478.80

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $3,016.69 2021-2025 Intellis Adaptivestim, Inceptiv, Synchromedii
Boston Scientific Corporation $1,684.05 2019-2025 Intracept, General - Pain Management
Abbott Laboratories $740.85 2022-2025 Proclaim, Eterna
Abbvie INC. $714.67 2021-2025
Curonix LLC $628.51 2022-2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Vertos Medical, INC. $542.63 2019-2024 Mild Device Kit
Horizon Therapeutics Plc $538.41 2019-2022
Medtronic USA, INC. $513.68 2019-2020
Stryker Corporation $468.08 2019-2025 Mild Device Kit
Collegium Pharmaceutical, INC. $409.53 2019-2025 Belbuca, Xtampza
Nalu Medical, INC. $354.68 2022-2025 Nalu Neurostimulation System
Biotronik Nro, INC. $353.56 2023-2025 Prospera, Biotronik
Spr Therapeutics, INC $352.47 2023-2025 Sprint Pns System
Nevro Corp. $261.54 2021-2024 Senza
Globus Medical, INC. $249.52 2025 Senza
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Relievant Medsystems, INC. $238.30 2021-2022
Si-Bone, INC. $238.16 2019-2025
Stimwave Technologies Incorporated $220.23 2019-2022
Spinal Simplicity, LLC $204.47 2022
Grt US Holding, INC. $192.32 2020-2022
Pfizer INC. $151.91 2019-2024
Mml US, INC. $145.77 2022
Stratus Medical, LLC $135.21 2022
Teva Pharmaceuticals USA, INC. $129.31 2019-2021
Biohaven Pharmaceutical Holding Company LTD. $128.46 2022
Averitas Pharma INC. $122.87 2023-2025 Qutenza
Fidia Pharma USA INC. $111.12 2021-2022
Biodelivery Sciences International, INC. $73.57 2019-2021
Amgen INC. $72.42 2021-2022
Zyla Life Sciences, INC. $65.32 2019-2020
Pacira Therapeutics, INC. $61.94 2021
Brainsway USA INC $53.57 2022
Amniox Medical, INC. $43.76 2020
Allergan, INC. $39.36 2019-2022
Convatec INC. $30.30 2025
Sentynl Therapeutics, INC. $28.63 2019
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $22.57 2023 Relistor
Novo Nordisk INC $17.32 2024 Wegovy
Lundbeck LLC $16.95 2023 Vyepti
Saluda Medical Americas, INC. $16.85 2024 Evoke
Lilly USA, LLC $16.49 2021
Fujifilm Sonosite, INC. $16.11 2019
Ibsa Pharma INC. $16.06 2024 Flector, Licart, Tirosint
Bioventus LLC $15.82 2021
Electronic Waveform Lab, INC. $10.22 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Seema Rasheed

$13,464.26

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $1,866 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

https://glasscript.com/doctor/263309/seema-rasheed

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.